Tenon Medical, Inc. (NASDAQ:TNON) Short Interest Update

Tenon Medical, Inc. (NASDAQ:TNON) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 135,400 shares, a drop of 34.5% from the October 31st total of 206,700 shares. Based on an average daily volume of 2,550,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 4.3% of the shares of the company are short sold.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Benchmark reaffirmed a “speculative buy” rating and issued a $3.00 price target on shares of Tenon Medical in a report on Wednesday, August 14th. Maxim Group dropped their target price on Tenon Medical from $22.00 to $8.00 and set a “buy” rating on the stock in a report on Friday, November 15th.

Tenon Medical Trading Down 2.5 %

TNON traded down $0.06 during trading on Thursday, reaching $2.34. 173,398 shares of the company were exchanged, compared to its average volume of 731,271. Tenon Medical has a 52 week low of $2.20 and a 52 week high of $20.00. The stock has a market cap of $7.35 million, a P/E ratio of -0.09 and a beta of 2.15. The firm has a 50 day moving average of $3.70 and a 200 day moving average of $1.96.

About Tenon Medical

Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.